CINECA IRIS Institutional Research Information System

TROIA, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.290
EU - Europa 1.303
AS - Asia 1.019
SA - Sud America 129
OC - Oceania 31
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.786
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.180
CN - Cina 416
IT - Italia 378
FR - Francia 183
IN - India 139
JP - Giappone 136
GB - Regno Unito 105
SG - Singapore 84
SE - Svezia 82
ES - Italia 77
DE - Germania 74
CA - Canada 68
IE - Irlanda 67
BR - Brasile 52
NL - Olanda 50
IL - Israele 44
TR - Turchia 44
UA - Ucraina 44
CH - Svizzera 36
AT - Austria 30
HK - Hong Kong 29
MX - Messico 28
GR - Grecia 27
PL - Polonia 27
VN - Vietnam 25
AU - Australia 24
PT - Portogallo 24
CO - Colombia 21
CL - Cile 20
FI - Finlandia 20
TW - Taiwan 18
NO - Norvegia 17
KR - Corea 15
SA - Arabia Saudita 15
BE - Belgio 14
RU - Federazione Russa 14
AR - Argentina 11
ID - Indonesia 11
UY - Uruguay 11
KW - Kuwait 9
DK - Danimarca 8
QA - Qatar 8
TH - Thailandia 8
HU - Ungheria 7
CZ - Repubblica Ceca 6
NZ - Nuova Zelanda 6
PE - Perù 6
TT - Trinidad e Tobago 6
AM - Armenia 4
EU - Europa 4
KY - Cayman, isole 4
ZA - Sudafrica 4
EC - Ecuador 3
EE - Estonia 3
GF - Guiana Francese 3
PH - Filippine 3
RO - Romania 3
SI - Slovenia 3
UZ - Uzbekistan 3
CR - Costa Rica 2
EG - Egitto 2
IS - Islanda 2
MY - Malesia 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
IR - Iran 1
JM - Giamaica 1
LB - Libano 1
NG - Nigeria 1
NP - Nepal 1
PF - Polinesia Francese 1
PK - Pakistan 1
PR - Porto Rico 1
PY - Paraguay 1
SN - Senegal 1
TG - Togo 1
TN - Tunisia 1
VE - Venezuela 1
Totale 5.786
Salva come PNG Salva come JPEG
Città #
Houston 369
Redwood City 132
Fairfield 121
Florence 115
Cambridge 103
Chandler 83
Ashburn 72
Beijing 69
Santa Clara 66
Dublin 62
Singapore 60
Tokyo 47
Shanghai 46
Los Angeles 45
Torino 44
Portland 43
Minneapolis 42
Wilmington 42
Chicago 41
Seattle 40
Woodbridge 40
Ann Arbor 39
Indianapolis 38
Paris 38
Columbus 33
Turin 33
New York 31
Hangzhou 29
Guangzhou 28
Nanjing 28
Baltimore 27
Rochester 26
Nyköping 23
Medford 22
Ottawa 21
London 20
Philadelphia 20
Providence 20
Athens 19
Hyderabad 19
Norwalk 19
Charlotte 18
Madrid 18
Toronto 18
Boston 17
Duncan 17
Saint Paul 17
San Diego 17
Santiago 17
Tel Aviv 17
Vienna 17
Princeton 16
San Francisco 16
Jacksonville 15
Loma Linda 14
Wuhan 14
Breda 13
Pittsburgh 13
St Louis 13
Dong Ket 12
Helsinki 12
Honolulu 12
Mumbai 12
Pisa 12
Toledo 12
Aurora 11
Chengdu 11
Flushing 11
Grand Rapids 11
Greenville 11
Jakarta 11
Montevideo 11
Notre Dame 11
Scarsdale 11
Stockholm 11
Temple 11
Bogotá 10
Cincinnati 10
Lancaster 10
Louisville 10
Newbury Park 10
Reading 10
Shenyang 10
Dearborn 9
Miami 9
Omaha 9
Orlando 9
Queens 9
Salt Lake City 9
San Francesco 9
Seoul 9
Vedène 9
Warsaw 9
Amsterdam 8
Atlanta 8
Bengaluru 8
Clemmons 8
Doha 8
Durham 8
Kansas City 8
Totale 2.911
Salva come PNG Salva come JPEG
Nome #
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 2.899
Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma 797
Melphalan hydrochloride for the treatment of multiple myeloma 725
Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma 225
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma 205
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis 204
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis 181
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial 155
Promises and pitfalls in the use of PD-1/PD-L1 inhibitors in multiple myeloma 132
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma 112
Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma 110
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study 77
Monoclonal antibodies currently in Phase II and III trials for multiple myeloma 64
Totale 5.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020569 0 0 0 0 0 16 57 168 192 60 49 27
2020/2021896 18 29 101 60 72 101 83 100 94 78 73 87
2021/20221.113 67 70 75 92 98 55 176 92 65 80 118 125
2022/20231.089 66 87 81 83 75 113 91 92 110 103 103 85
2023/20241.107 81 105 89 100 92 101 114 121 30 89 85 100
2024/2025720 102 90 138 113 173 104 0 0 0 0 0 0
Totale 5.886